The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort

Author： Abu Dayyeh Barham   Yang May   Dienstag Jules   Chung Raymond  

Publisher： Springer Publishing Company

ISSN： 0163-2116

Source： Digestive Diseases and Sciences, Vol.56, Iss.2, 2011-02, pp. : 564-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation

By Fabris Carlo   Toniutto Pierluigi   Bitetto Davide   Minisini Rosalba   Fornasiere Ezio   Smirne Carlo   Pirisi Mario  

Journal of Gastroenterology, Vol. 42, Iss. 7, 2007-07 ,pp. : 543-549

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-10 promoter polymorphisms and liver fibrosis progression in patients with chronic hepatitis C in Japan

By Hamada H.   Yatsuhashi H.   Yano K.   Arisawa K.   Nakao K.   Yano M.  

Journal of Hepatology, Vol. 39, Iss. 3, 2003-09 ,pp. : 457-458

Elsevier

Access to resources Recommend Favorite

Renin–angiotensin system and progression of chronic liver diseases

By Yoshiji Hitoshi   Fukui Hiroshi  

Journal of Gastroenterology, Vol. 41, Iss. 10, 2006-10 ,pp. : 1020-1022

Springer Publishing Company

Access to resources Recommend Favorite

Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 1, 2005-01 ,pp. : 61-67

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis

By  

Digestive Diseases, Vol. 33, Iss. 2, 2015-0 ,pp. : 115-117

Karger

Access to resources Recommend Favorite